Viking Thera (VKTX)
$6.83 0.10 (1.44%)
17:56 EST VKTX Stock Quote Delayed 15 Minutes
Previous Close $6.83
Market Cap 406.78M
PE Ratio -10.35
Volume (Avg. Vol.) 1.45M
Day's Range 6.53 - 6.90
52-Week Range 6.10 - 11.03
Dividend & Yield N/A (N/A)
VKTX Stock Predictions, Articles, and Viking Thera News
- From InvestorPlace
- From the Web
Viking Therapeutics stock got a boost from Gilead's failure earlier this week, but does that make VKTX stock a buy? Let's look.
Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.
Viking Therapeutics (VKTX) stock was entering orbit on Tuesday after releasing results from a recent study concerning fatty liver treatment.
Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.
Biotech's luck is changing as the trend looks to be upward and outward for the biotech stocks. These are the five to watch.
From Market News Video
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in WideOpenWest Inc (WOW), where a total of 1,340 contracts have traded so far, representing approximately 134,000 underlying shares. That amounts to about 44.8% of WOW's average daily trading volume over the past month of 298,940 shares..
Navellier RatingsPowered by Portfolio Grader